Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.61
-5.50 (-2.62%)
AAPL  266.67
+2.09 (0.79%)
AMD  194.78
-5.37 (-2.68%)
BAC  51.23
-1.83 (-3.44%)
GOOG  311.29
-3.61 (-1.15%)
META  637.88
-17.77 (-2.71%)
MSFT  383.49
-13.75 (-3.46%)
NVDA  190.72
+0.90 (0.47%)
ORCL  140.05
-8.03 (-5.42%)
TSLA  395.30
-16.52 (-4.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.